News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Burstein Jennifer
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/15/2023 |
4
| Burstein Jennifer (Director) has filed a Form 4 on Stoke Therapeutics, Inc.|
Txns:
| Granted 19,441 options to buy
@ $12.46, valued at
$242.2k
|
|
| 06/08/2022 |
4
| Burstein Jennifer (Director) has filed a Form 4 on Stoke Therapeutics, Inc.|
Txns:
| Granted 21,000 options to buy
@ $12.96, valued at
$272.2k
|
|
| 06/25/2021 |
4
| Burstein Jennifer (Director) has filed a Form 4 on Stoke Therapeutics, Inc.|
Txns:
| Granted 11,650 options to buy
@ $40.37, valued at
$470.3k
|
|
| 06/05/2020 |
4
| Burstein Jennifer (Director) has filed a Form 4 on Stoke Therapeutics, Inc.|
Txns:
| Granted 14,777 options to buy
@ $26.53, valued at
$392k
|
|
| 09/12/2019 |
4
| Burstein Jennifer (Director) has filed a Form 4 on Stoke Therapeutics, Inc.|
Txns:
| Granted 29,555 options to buy
@ $28.8, valued at
$851.2k
|
|
| 02/15/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/02/2019 |
4
| Burstein Jennifer (Senior VP of Finance) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Granted 20,000 options to buy
@ $139.77, valued at
$2.8M
|
|
| 12/12/2018 |
4
| Burstein Jennifer (Senior VP of Finance) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Sold 100 shares
@ $130.79, valued at
$13.1k
Sold 400 shares
@ $132.44, valued at
$53k
Sold 100 shares
@ $133.34, valued at
$13.3k
Sold 550 shares
@ $134.71, valued at
$74.1k
Sold 100 shares
@ $136.04, valued at
$13.6k
Sold 200 shares
@ $135.69, valued at
$27.1k
Sold 587 shares
@ $136.98, valued at
$80.4k
Sold 263 shares
@ $137.88, valued at
$36.3k
Sold 100 shares
@ $139.36, valued at
$13.9k
Sold 100 shares
@ $140.48, valued at
$14k
Exercised 1,250 options to buy
@ $11.35, valued at
$14.2k
|
|
| 11/28/2018 |
4
| Burstein Jennifer (Senior VP of Finance) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Sold 500 shares
@ $151.57, valued at
$75.8k
Sold 250 shares
@ $152.39, valued at
$38.1k
Sold 100 shares
@ $153.3, valued at
$15.3k
Sold 300 shares
@ $155.13, valued at
$46.5k
Sold 100 shares
@ $156.04, valued at
$15.6k
Sold 200 shares
@ $137.89, valued at
$27.6k
Sold 350 shares
@ $138.95, valued at
$48.6k
Sold 200 shares
@ $140.94, valued at
$28.2k
Sold 200 shares
@ $143.84, valued at
$28.8k
Sold 100 shares
@ $147.09, valued at
$14.7k
Sold 100 shares
@ $148.2, valued at
$14.8k
|
|
| 10/05/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/14/2018 |
4
| Burstein Jennifer (Senior VP of Finance) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Sold 550 shares
@ $166.1391, valued at
$91.4k
Sold 200 shares
@ $167.25, valued at
$33.5k
Sold 200 shares
@ $168.785, valued at
$33.8k
Sold 300 shares
@ $170.95, valued at
$51.3k
Sold 750 shares
@ $165.5267, valued at
$124.1k
Sold 500 shares
@ $166.756, valued at
$83.4k
Exercised 1,250 options to buy
@ $11.35, valued at
$14.2k
Exercised 1,250 options to buy
@ $11.35, valued at
$14.2k
|
|
| 08/15/2018 |
4
| Burstein Jennifer (Senior VP of Finance) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Sold 800 shares
@ $158.0025, valued at
$126.4k
Sold 440 shares
@ $158.6882, valued at
$69.8k
Sold 10 shares
@ $160.17, valued at
$1.6k
Sold 450 shares
@ $159.4656, valued at
$71.8k
Sold 800 shares
@ $160.6488, valued at
$128.5k
Exercised 1,250 options to buy
@ $11.35, valued at
$14.2k
Exercised 1,250 options to buy
@ $11.35, valued at
$14.2k
|
|
| 07/11/2018 |
4
| Burstein Jennifer (Senior VP of Finance) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Sold 200 shares
@ $184.72, valued at
$36.9k
Sold 500 shares
@ $186.666, valued at
$93.3k
Sold 600 shares
@ $187.5283, valued at
$112.5k
Sold 100 shares
@ $189.12, valued at
$18.9k
Sold 100 shares
@ $191.64, valued at
$19.2k
Exercised 1,500 options to buy
@ $11.35, valued at
$17k
|
|
| 06/21/2018 |
4
| Burstein Jennifer (Senior VP of Finance) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Sold 800 shares
@ $176.2898, valued at
$141k
Sold 500 shares
@ $177.15, valued at
$88.6k
Sold 400 shares
@ $178.2025, valued at
$71.3k
Exercised 1,700 options to buy
@ $11.35, valued at
$19.3k
|
|
| 05/16/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/26/2018 |
4
| Burstein Jennifer (Senior VP of Finance) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Sold 300 shares
@ $129.4551, valued at
$38.8k
Sold 300 shares
@ $130.77, valued at
$39.2k
Sold 800 shares
@ $132.0625, valued at
$105.7k
Sold 300 shares
@ $133.6233, valued at
$40.1k
Exercised 1,700 options to buy
@ $11.35, valued at
$19.3k
|
|
| 03/15/2018 |
4
| Burstein Jennifer (Senior VP of Finance) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Sold 100 shares
@ $128.85, valued at
$12.9k
Sold 700 shares
@ $130.2286, valued at
$91.2k
Sold 500 shares
@ $131.754, valued at
$65.9k
Sold 300 shares
@ $133.04, valued at
$39.9k
Sold 100 shares
@ $134.28, valued at
$13.4k
Exercised 1,700 options to buy
@ $11.35, valued at
$19.3k
|
|
| 02/14/2018 |
4
| Burstein Jennifer (Senior VP of Finance) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Sold 300 shares
@ $91.6133, valued at
$27.5k
Sold 600 shares
@ $92.865, valued at
$55.7k
Sold 700 shares
@ $94.0401, valued at
$65.8k
Sold 100 shares
@ $94.73, valued at
$9.5k
Exercised 1,700 options to buy
@ $11.35, valued at
$19.3k
|
|
| 01/18/2018 |
4
| Burstein Jennifer (Senior VP of Finance) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Sold 1,500 shares
@ $87.4952, valued at
$131.2k
Exercised 1,500 options to buy
@ $11.35, valued at
$17k
|
|
| 01/05/2018 |
4
| Burstein Jennifer (Senior VP of Finance) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Granted 40,000 options to buy
@ $84.88, valued at
$3.4M
|
|
| 12/18/2017 |
4
| Burstein Jennifer (Vice President of Finance) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Sold 900 shares
@ $82.6646, valued at
$74.4k
Sold 800 shares
@ $83.9447, valued at
$67.2k
Exercised 1,700 options to buy
@ $11.35, valued at
$19.3k
|
|
| 11/29/2017 |
4
| Burstein Jennifer (Vice President of Finance) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Sold 1,100 shares
@ $74.19, valued at
$81.6k
Sold 300 shares
@ $75.1833, valued at
$22.6k
Sold 300 shares
@ $76.7633, valued at
$23k
Exercised 1,700 options to buy
@ $11.35, valued at
$19.3k
|
|
| 11/01/2017 |
4
| Burstein Jennifer (Vice President of Finance) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Sold 1,300 shares
@ $86.8877, valued at
$113k
Sold 200 shares
@ $87.7735, valued at
$17.6k
Sold 200 shares
@ $88.55, valued at
$17.7k
Exercised 1,700 options to buy
@ $11.35, valued at
$19.3k
|
|
| 09/20/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/16/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/17/2017 |
4
| Burstein Jennifer (Vice President of Finance) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Granted 12,000 options to buy
@ $43.56, valued at
$522.7k
|
|
| 12/08/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|